Risk of acute kidney injury and cost-effectiveness analysis comparing vancomycin and linezolid for the treatment of pediatric patients infected with Gram-positive bacteria.

Autor: de Jesus Oliveira, Laiane, Campos Ricieri, Marinei, Milan Fachi, Mariana, Miyake Okumura, Lucas, Araújo Motta, Fábio

Publikováno v: JBES: Brazilian Journal of Health Economics / Jornal Brasileiro de Economia da Saúde; 2022 Supplement, Vol. 14, p226-235, 10p